A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029)
Clinical trial NCT00692458 · WITHDRAWN
Trial details
- NCT number
- NCT00692458
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2008-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.